CSA Medical pulls in $8.3M for tissue-ablation device
CSA Medical, a Baltimore developer of endoscopic cryoablation systems, raised $8.3 million in a first round of funding, VentureWire reports (subscription required). New Markets Growth Fund and angel investors provided the funding.
CSA Medical makes and sells a device it calls the CryoSpray Ablation system, which delivers a spray of liquid nitrogen via endoscope to freeze and remove cancerous and precancerous tissue inside the body.
Next Story: Gentis raises $10M for spine-injected implants
Previous Story: Yahoo buys sports network, Rivals.com
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.